Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: A children's cancer group study

Leukemia and Lymphoma

Volumn 24, Issue 1-2, 1996, Pages 57-70

  Uckun, Fatih M ^a   Reaman, Gregory ^b   Steinherz, Peter G ^b   Arthur, Diane C ^b   Sather, Harland ^b   Trigg, Michael ^b   Tubergen, David ^b   Gaynon, Paul ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; HUMAN; IMMUNOPHENOTYPING; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; T CELL LEUKEMIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, T-CELL, ACUTE; MALE; PROGNOSIS; TREATMENT OUTCOME;

EID: 0030467761     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609045714     Document Type: Article

References (48)

1. Greaves, M. F. (1986). Differentiation-linked leukemogenesis in lymphocytes, Science, 234, 697.
2. Champlin, R. and Gale, R. P. (1989). Acute lymphoblastic leukemia: Recent advances in biology and therapy, Blood, 73, 2051.
3. Smith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E., Link, M., Murphy, S., Pui, C.-H., Pullen, J., Reaman, G., Sallon, S. E., Sather, H., Shuster, J., Simon, R., Trigg, M., Uckun, F. and Ungerleider, R. (1996). A uniform approach to risk-classification and treatment assignment for children with acute lymphoblastic leukemia (ALL), J. Clin. Oncol., 14, 18.
4. Pui, C. H. (1995). Childhood leukemias, N. Eng. J. Med., 332, 1618.
5. Larson, R. A., Dodge, R. K., Burns, C. P., Lee, E. J., Stone, R. M., Schulman, P., Duggan, D., Davey, F R., Sobol, R. E., Frankel, S. R., Hooberman, A. L., Westbrook, C. A., Arthur, D. C., George, S. L., Bloomfield, C. D. and Schiffer, C. A. (1995). A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8881, Blood, 85, 2025.
6. Hoelzer, D., Tiel, E., Loffler, Buchner, T., Ganser, A., Heil, G., Koch, P , Freund, M., Diedrich, H., Ruhl, H., Maschmeyer, G., Lipp, T., Nowrousian, M. R., Burkert, M., Gerecke, D., Pralle, H., Muller, U., Lunscken, Ch, Fulle, H., Ho, A. D., Kuchler, R., Busch, F. W., Schneider, W., Gorg, Ch, Emmerich, B., Braumann, D., Vaupel, H. A., Von Paleske, A., Bartles, H., Neiss, A., Messerer, D. (1988). Prognostic factors in a multi-center study for treatment of acute lymphoblastic leukemia in adults, Blood, 17, 123.
7. Reiter, A., Schrappe, M., Ludwig, W. D., Hiddemann, W., Sauter, S., Henze, G., Zimmermann, M., Lampert, F., Havers, W., Niethammer, D., Odenwald, E., Riter, J., Mann, G., Welte, K., Gadner, H., Riehm, H (1994). Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86, Blood, 84, 3122.
8. Trigg, M. E., Gaynon, P., Uckun, F M. (1996). Acute lymphoblastic leukemia in children. In: Cancer Medicine, 4th Edition (edited James F. Holland, Emile Fry III, Robert C. Bast, Jr., Donald W. Kufe, Donald L. Morton, Ralph R. Weichselbaum). in press.
9. Shorin, M. A., Blattner, S., Gelber, R. D., Tarbell, N. J , Donnelly, M. Dalton, V., Cohen, H. J., Sallan, S. E. (1994). Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium protocol 85-01, J. Clin. Oncol., 12, 740.
10. Foon, K. A., Tood, R. F., III. (1986). Immunologic classification of leukemia and lymphoma, Blood, 68, 1.
11. Pui, C. H., Behm, F. G., Crist, W. M. (1993). Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia, Blood, 82, 343.
12. Reinherz, E. L., Kung, P. C., Goldstern, G., Levey, R. H., Schlossman, S. F. (1980). Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage, Proc. Natl. Acad. Sci. USA, 77, 1588.
13. Crist, W., Shuster, J., Look, T., Borowitz, M., Behm, F , Bowman, P., Frankel, L., Pullen, J., Krance, R., Steuber, P., Camitta, B., Amylon, M., Link, M., Land, V. (1992). Current results of studies of immunophenotype-, age-and leukocyte-based therapy for children with acute lymphoblastic leukemia, Leukemia, 6, 162.
14. Shuster, J J., Falletta, J. M., Pullen, D. J , Crist, W. M., Humphrey, G. B., Dowell, B. L., Wharam, M. D., Borowitz, M. (1990). Prognostic factors in childhood T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study, Blood, 75, 166.
15. Pui, C. H., Behm, F. G., Singh, B., Schell, M. J., Williams, D. L., Rivera, G. K , Kalwinsky, D. K., Sandlund, J. T., Crist, W. M., Raimondi, S. C. (1990) Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia, Blood, 75, 174.
16. 2 treatment in 53 children with E-rosette-positive T-cell leukemia: Results and prognostic factors: A Pediatric Oncology Group Study, Blood, 60, 1159.
17. Borowitz, M. J., Dowell, M. L., Boyett, J. M., Pullen, J., Crist, W. M., Quddus, F. M., Falletta, J. M., Metzgar, R. S. (1986). Clinicopathologic aspects of E rosette negative T-cell acute lymphocytic leukemia: A Pediatric Oncology Group study, J. Clin. Oncol., 4, 170.
18. Gaynon, P., Stemherz, P., Bleyer, W. A., Ablin, A., Albo, V., Finkelstein, J., Grossman, N., Littman, P., Novak, L., Pyesmany, A., Reaman, G., Sather, H., Hammond, D. (1988) Intensive therapy for children with acute lymphoblastic leukemia and unfavorable presenting features, Lancet, ii, 921.
19. Steinherz, P., Gaynon, P., Miller, D., Reaman, G., Bleyer, W. A., Finkelstein, J., Evans, R., Meyers, P., Steinherz, L., Sather, H., Hammond, D (1986). Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York Regimen - A new intensive therapy protocol, J. Clin. Oncol., 4, 744.
20. Tubergen, D., Gilchrist, G., O'Brien, R., Coccia, P., Sather, H., Waskerwitz, M , Hammond, D. (1993). Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features, J Clin. Oncol., 11, 527.
21. Uckun, F. M., Myers, D. E , Jaszcz, W , Haissig, S., Gajl-Peczalska, K., Ledbetter, J. A. (1990). Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells, Blood, 76, 2449.
22. Uckun, F. M., Gajl-Peczalska, K. J., Provisor, A. J , Heerema, N A. (1989). Immunophenotype-karyotype associations in human acute lymphoblastic leukemia, Blood, 73, 271.
23. Uckun, F. M., Ledbetter, J. A. (1988). Immunobiologic differences between normal and leukemic human B-cell precursors, Proc. Natl. Acad. Sci. USA, 85, 8603.
24. + acute lymphoblastic leukemia and their putative normal counterparts in human fetal hernatopoietic tissues, Blood, 73, 1000.
25. Gaynon, P., Steinherz, P., Bleyer, W. A , Albin, A., Albo, V., Finkelstein, J., Grossman, N., Novak, L., Pyesmany, A., Reaman, G., Chappell, R., Sather, H., Hammond, D. (1993). Improved therapy for children with acute lymphoblastic leukemia and unfavorable features: A follow-up report of the Childrens Cancer Group Study CCG-106. J. Clin. Oncol., 11, 2234.
26. Gaynon, P. A., Bostrom, B., Reaman, G., Sather, H., Trigg, M. E., Tebergen, D. G., Uckun, F. M. (1996). Childrens Cancer Group (CCG) initiatives in childhood acute lymphoblastic leukemia (ALL), Am. J. Pediatri. Hematol /Oncol., in press.
27. Gaynon, P., Bleyer, W. A., Stienherz, P., Finkelstein, J., Littman, P., Miller, D., Reaman, G., Sather, H., Hammond, D. (1988). Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable features, Am. J. Pediatri, Hematol./Oncol., 10, 42.
28. Trigg, M., Gaynon, P., Reaman, G., Steinherz, P., Sather, H., Cairo, M., Hammond, D. (1993). Treatment strategy for children with acute lymphoblastic leukemia and unfavorable features: CCG studies. In: Cancer Chemotherapy: Challenges for the Future, Vol. 8, Excerpta Medica, Ltd./Tokyo, pp. 260-267.
29. Tubergen, D., Gilchrist, G., O'Brien, R., Coccia, P., Sather, H., Waskerwitz, M , Hammond, D. (1993). Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy, J. Clin Oncol., 11, 520.
30. Cherlow, J., Steinher, P., Sather, H., Gaynon, P., Grossman, N , Kersey, J., Maurer, H., Brenneman, J., Trigg, M., Hammond, D. (1993). The role of radiation therapy in the treatment of acute lymphocytic leukemia with lymphomatous presentation, Int. J. Radiat. Oncol., Biol, Phys., 27, 1001.
31. Reaman, G., Feusnew, J., Heerema, N., Steinherz, P. G., Zeltzer, P , Bleyer, W. A , Sather, H., Hammond, G D. (1989). Intensive systemic intrathecal chemotherapy improves the outcome for infants with acute lymphoblastic leukemia, Proc. Am. Soc. Clin. Oncol., 34, (Abstract).
32. Kaplan, E., Meier, P. (1958). Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc., 53, 457.
33. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother. Rep., 50, 163.
34. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J , Smith, P. G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and examples, Br. J. Cancer, 35, 1
35. Breslow, N. (1975). Analysis of survival data under the proportional hazards model, Int. Stat. Rev , 43, 45.
36. Cox, D. R. (1972). Regression models and life tables, J. R. Stat. Soc. B., 34, 187-220.
37. Thomas, D., Breslow, N., Gart, J (1977). Trend and homogeneity analyses of proportions and life table data, Comput. Biomed. Res., 10, 373.
38. Sen, L. S., Borella, L. (1975). Clinical importance of lymphoblasts with T-markers in childhood acute leukemia, N. Engl. J. Med., 292, 828.
39. Greaves, M. F., Janossy, G., Peto, J., Kay, H. (1981). Immunologically defined subclasses of acute lymphoblastic leukemia in children. Their relationship to presentation and prognosis. Br. J. Haematol., 48, 179.
40. Greaves, M. F. (1981). Biological basis of differential prognosis in immunologically defined subclases of acute lymphoblastic leukemia. In: Leukemia Markers (edited by W. Knapp). Academic Press: New York/London pp. 463.
41. Niemeyer, C. M., Hitchcock-Bryan, S., Sallan, S E. (1985). Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia, Semin. Oncol., 12, 122.
42. Goldie, J. H., Coldman, A. J. (1984). The genetic origin of drug resistanc ein neoplasms: Implications for system therapy, Cancer Reserach, 44, 3643.
43. Norton, L., Simon, R. (1977). Tumor size and sensitivity to therapy and design of treatment schedules, Cancer Treatment Report, 61, 1307
44. Rivera, G. K , Raimondi, S. C., Hancock, M. L, Behm, F G., Pui, Ch., Abramowitch, M., Mirro, J., Jr., Ocks, Js., Look, A. T., Williams, D. L., Murphy, S. B., Dhl, G. V., Kalwinsky, D. K., Evans, W. E., Kun, L. E., Simone, J. V., Crist, W. M. (1991). Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy, Lancet, 337, 61.
45. Chessells, J. M., Bailey, C., Richards, S. M. (1995). Intensification of treatment and survival in all children with lymphoblastic leukemia: Results of the UK Medical Research Council trial UKALL X, Lancet, 345, 143.
46. Rabbitts, T H. (1994). Chromosomal translocations in human cancer, Nature, 372, 143.
47. Uckun, F. M., Reaman, G. H. (1995). Immunotoxins for treatment of leukemia and lymphoma, Leukemia and Lymphoma, 18, 195.
48. Uckun, F. M., Evans, W. E., Forsyth, C. J., Waddick, K. G., T-Ahlgren, L., Chelstrom, L M., Burkhardt, A., Bolen, J., Myers, D. E. (1995). Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases, Science, 267, 886.